Correlation Between Diamyd Medical and Clearside Biomedical

Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Diamyd Medical AB and Clearside Biomedical, you can compare the effects of market volatilities on Diamyd Medical and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and Clearside Biomedical.

Diversification Opportunities for Diamyd Medical and Clearside Biomedical

0.57

Correlation Coefficient

Diamyd Medical  Clearside Biomedical

Very weak diversification

The 3 months correlation between Diamyd and Clearside is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and Clearside Biomedical go up and down completely randomly.

Pair Corralation between Diamyd Medical and Clearside Biomedical

Assuming the 90 days horizon Diamyd Medical AB is expected to under-perform the Clearside Biomedical. In addition to that, Diamyd Medical is 1.8 times more volatile than Clearside Biomedical. It trades about -0.17 of its total potential returns per unit of risk. Clearside Biomedical is currently generating about 0.04 per unit of volatility. If you would invest  89.00  in Clearside Biomedical on December 30, 2024 and sell it today you would earn a total of  4.00  from holding Clearside Biomedical or generate 4.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Diamyd Medical AB  vs.  Clearside Biomedical

Diamyd Medical AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Clearside Biomedical

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clearside Biomedical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile primary indicators, Clearside Biomedical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Diamyd Medical and Clearside Biomedical

The main advantage of trading using opposite Diamyd Medical and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.

The idea behind Diamyd Medical AB and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.